Monday, October 15, 2018 9:18:15 PM
https://finance.yahoo.com/news/elev8-brands-inc-approved-trading-135618986.html
ORLANDO, Fla., Oct. 15, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Elev8 Brands, Inc. (OTCQB: VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, hemp tea, hemp Cold Brew, CBD salve, CBD Lotions and CBD Tinctures that target the health and wellness markets, is pleased to announce it has been approved for trading on the OTCQB Venture Market.
Elev8 Brands, Inc. has been working diligently to make this come to fruition for its shareholders. The OTCQB provides a more transparent platform with fully audited financial statements as well as a stringent review process from OTC Markets.
CEO of Elev8 Brands, Inc., Ryan Medico, stated, “We are very excited to bring this news to our shareholders. Having that said, the development of our Hemp Cold Brew has been progressing and we will be putting out an update on this shortly. In addition, our entry into Canada has opened many doors for expansion as we have several meetings scheduled for this week. We will keep everyone updated as news progresses. Elev8 Brands is alive and well.”
About Elev8 Brands, Inc.:
Elev8 Brands, Inc. specializes in the development and marketing of products for the fitness and wellness markets. The company is founded based on creating high-quality, sustainable, products for health-conscious consumers.
About Elev8 Hemp LLC:
Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee and hemp tea.
About 02 Breathe LLC:
02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and massage products. 02 Breathe is currently looking to offer CBD at their oxygen bar.
About Zoe CBD LLC:
Zoe CBD is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of CBD-based products such as CBD Tinctures, CBD E-Juice, CBD Lotion and CBD Salve.
Please visit, http://www.zoecbd.com for more information
www.facebook.com/elev8hemp www.instagram.com/elev8hemp
www.twitter.com/elev8hemp www.02breathe.com
www.elev8hemp.com
SLEEKSCAPE’S GRAND SALAMI FOR 2018 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE$-GRAND-SALAMI-FOR-2018-HEMP-&-MARIJUANA-MANIA-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • InvestorsHub NewsWire • 04/16/2024 12:30:00 PM
- Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract • InvestorsHub NewsWire • 04/09/2024 12:30:00 PM
- Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation • InvestorsHub NewsWire • 04/04/2024 12:30:00 PM
- Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc. • InvestorsHub NewsWire • 03/12/2024 01:54:43 PM
- Shares of this Biotech Holdings Company Up on LOI • AllPennyStocks.com • 02/29/2024 06:10:00 PM
- Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC • InvestorsHub NewsWire • 02/29/2024 01:30:00 PM
- Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL • InvestorsHub NewsWire • 02/08/2024 01:30:00 PM
- Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market • InvestorsHub NewsWire • 02/06/2024 02:30:00 PM
- Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00 • InvestorsHub NewsWire • 01/30/2024 02:25:00 PM
- Branded Legacy, Inc. Reduces Debt by 1.5 Million • InvestorsHub NewsWire • 01/25/2024 01:30:00 PM
- Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M • InvestorsHub NewsWire • 01/23/2024 01:30:00 PM
- Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets • InvestorsHub NewsWire • 12/05/2023 01:00:00 PM
- Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • InvestorsHub NewsWire • 11/28/2023 12:23:33 PM
- Branded Legacy Signs Letter of Intent to Acquire $6 Million in Assets and Additional Facility Space • InvestorsHub NewsWire • 11/16/2023 12:00:00 PM
- Branded Legacy, Inc. Announces 1.5B Reduction in Authorized Share Count • InvestorsHub NewsWire • 11/09/2023 12:03:15 PM
- Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements • InvestorsHub NewsWire • 11/07/2023 12:02:43 PM
- Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow • InvestorsHub NewsWire • 10/26/2023 12:30:00 PM
- Rocket Web Development & Design: Navigating the Digital Frontier with Innovation and Excellence • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023 • InvestorsHub NewsWire • 10/19/2023 12:00:00 PM
- Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion • InvestorsHub NewsWire • 10/10/2023 12:25:00 PM
- Total Refinement Solutions LLC Transitions to Royal Biotek Under $BLEG Portfolio • InvestorsHub NewsWire • 10/05/2023 12:18:33 PM
- Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- Branded Legacy Inc. Unveils Exciting Q4 2023 Milestones and Forges Ahead with Key Partnerships • InvestorsHub NewsWire • 09/28/2023 02:44:40 PM
- Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • InvestorsHub NewsWire • 09/26/2023 02:37:45 PM
- Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans • InvestorsHub NewsWire • 09/12/2023 11:30:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM